Recent Posts in Dangerous Drugs Category
AAJ: FDA Warning To Glaxo Highlights Dangers Of Preemption
Posted By Goodman Acker P.C.
April 15, 2008 (Washington, DC) — As reported in the Wall Street Journal, the Food and Drug Administration (FDA) has issued a serious warning to GlaxoSmithKline after discovering the drugmaker did not inform the agency about clinical trials it was conducting on the diabetes drug Avandia between 2001 and 2007. Avandia has been linked to causing heart attacks and, in November 2007, the FDA ...
1 results found. Viewing page 1 of 1.